XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The components of income before income taxes are as follows:
Year Ended December 31,
202220212020
Domestic$2,523 $2,298 $233 
Foreign423 379 98 
$2,946 $2,677 $331 
The Company's provision for (benefit from) income taxes consist of the following:
Year Ended December 31,
202220212020
Current
Federal$473 $434 $(208)
State74 57 
Foreign123 93 14 
Total current
670 584 (188)
Deferred
Federal(1)19 154 
State(14)13 (13)
Foreign(6)(9)
Total deferred
(21)23 146 
Total provision for (benefit from) income taxes$649 $607 $(42)
A reconciliation of taxes computed at the statutory rate to the Company's income tax expense is as follows:
Year Ended December 31,
202220212020
Provision for federal income tax, at statutory rate$619 $563 $70 
State income tax provision, net of federal income tax effect59 56 
Foreign income tax rate differential30 22 
CARES Act net operating loss carryback tax benefit— — (95)
Noncontrolling interests(8)(11)(9)
Change in valuation allowance— (29)
U.S. federal research and development credits(27)(1)(2)
Other, net(24)(13)
Total income tax expense (benefit)
$649 $607 $(42)
The tax effects of the principal temporary differences between financial reporting and income tax reporting at December 31 are as follows:
20222021
Net operating loss carryforward$103 $96 
Credit carryforward19 23 
Operating lease liabilities149 136 
Accruals96 68 
Pension99 64 
Inventories34 22 
Research and experimental expenditures94 — 
Other18 26 
Deferred taxes assets—total612 435 
Property, plant and equipment(1,301)(1,134)
Intangibles(272)(288)
Operating lease right-of-use asset(149)(134)
Turnaround costs(49)(27)
Consolidated partnerships(234)(256)
Equity method investments(237)(223)
Other(42)(17)
Deferred tax liabilities—total(2,284)(2,079)
Valuation allowance(47)(4)
Total net deferred tax liabilities$(1,719)$(1,648)
Balance sheet classifications
Noncurrent deferred tax asset$16 $33 
Noncurrent deferred tax liability(1,735)(1,681)
Total net deferred tax liabilities$(1,719)$(1,648)
At December 31, 2022, the Company had federal, foreign and state net operating loss carryforwards ("NOLs") of approximately $18, $224 and $733, respectively. The federal NOL of $18 was acquired in connection with the acquisition of Dimex and a foreign NOL of $76 was acquired in connection with the acquisition of Westlake Epoxy. The federal NOL and certain foreign and state NOLs do not expire, while certain other foreign and state NOLs expire in varying amounts between 2023 and 2042. The federal NOL and certain state NOLs are subject to limitations on an annual basis. At December 31, 2022, the Company had various federal and state credits carryforwards of $2 and $17, respectively, which either do not expire or expire in varying amounts between 2028 and 2032. Management believes the Company will realize the benefit of a portion of the net operating loss carryforwards before they expire, but to the extent that the full benefit may not be realized, a valuation allowance has been recorded. The valuation allowance increased by $43 as a result of the Westlake Epoxy acquisition and management judgment regarding the realizability of certain foreign deferred tax assets including net operating loss carryforwards.
The Tax Cuts and Jobs Act of 2017 eliminated the option to deduct research and experimental expenditures immediately in the year incurred and requires taxpayers to capitalize and amortize such expenditures over five years for domestic expenditures and over fifteen years for foreign expenditures effective beginning January 1, 2022. As a result, the Company has identified research and experimental expenditures required to be capitalized and established a deferred tax asset of $94.
The Company has recognized a liability for uncertain income tax positions of $30 as of December 31, 2022. The Company does not believe it is likely that any material amounts will be paid in 2023. The ultimate resolution and timing of payment for remaining matters continues to be uncertain.
The Company files income tax returns in the U.S. federal jurisdiction, various states and foreign jurisdictions. The Company is no longer subject to examinations by tax authorities before the year 2014.